Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

Liver transplantation significantly improves the survival and quality of life of patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die while on the transplant list because of an insufficient number of donors and because of the lack of an accurate prediction of life expectancy. Although many prognostic models have been proposed in the last two decades to predict mortality in cirrhosis, the Child–Pugh score [1] is by far the most largely used both in clinical practice and in clinical research. Recently, the model for end stage liver disease (MELD) has replaced the Child–Pugh score in the United States for prioritizing liver donor allocation [2]. MELD is considered more reproducible than the Child– Pugh score because it does not include subjective variables such as ascites and encephalopathy. However, obtaining the score requires computing and it is, therefore, much less practical than the Child–Pugh score for individual estimates at the bedside. Moreover, the MELD score has not been proven to be superior to the Child–Pugh score in terms of predictive accuracy [3], and both may be unsatisfactory when applied separately to compensated and decompensated patients [4]. It is in fact well known that life expectancies in compensated and decompensated cirrhosis are strikingly different and it is, therefore, conceivable that prognostic indicators may be different or may have a different weight according to the disease stage [4]. In this article we outline the natural history of cirrhosis and report on a systematic review of the literature regarding predictors of mortality in cirrhosis in order to

[1]  E. Cabré,et al.  The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. , 1993, The American journal of gastroenterology.

[2]  F. Chang,et al.  Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. , 2005, Journal of hepatology.

[3]  H. Lautz,et al.  Predictors of one‐year pretransplant survival in patients with cirrhosis , 1991, Hepatology.

[4]  G. D’Amico,et al.  Survival and prognostic indicators in compensated and decompensated cirrhosis , 1986, Digestive Diseases and Sciences.

[5]  E. Christensen,et al.  Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. , 1989, Scandinavian journal of gastroenterology.

[6]  S Chevret,et al.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death , 2000, Gut.

[7]  R. Fisher,et al.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death , 2004, Hepatology.

[8]  E. Christensen,et al.  Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis , 1984, Hepatology.

[9]  T. Sauerbruch,et al.  Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. , 1991, Gastroenterology.

[10]  H. Nagashima,et al.  Follow-up study of 582 liver cirrhosis patients for 26 years in Japan. , 2008, Liver.

[11]  C. Madl,et al.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. , 2003, Gastroenterology.

[12]  F. Nevens Diagnosis of Portal Hypertension: How and When , 2001 .

[13]  J. Villeneuve,et al.  Prognostic value of the aminopyrine breath test in cirrhotic patients , 1986, Hepatology.

[14]  M. Siciliano,et al.  Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach. , 1985, Hepato-gastroenterology.

[15]  M. Hashizume,et al.  Prognostic significance of hepatic vein waveform by Doppler ultrasonography in cirrhotic patients with portal hypertension. , 1995, The American journal of gastroenterology.

[16]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[17]  M. Serra,et al.  Effect of Hepatitis C Virus Infection and Abstinence From Alcohol on Survival in Patients With Alcoholic Cirrhosis , 2003, Journal of clinical gastroenterology.

[18]  E. Christensen,et al.  Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B , 2000, Gut.

[19]  G. Corrao,et al.  Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation. , 1997, Italian journal of gastroenterology and hepatology.

[20]  R. Conant,et al.  Reproducibility of Predictor Variables from a Validated Clinical Rule , 1992, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  V. Muls,et al.  Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. , 1995, Journal of hepatology.

[22]  A. Morabito,et al.  Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. , 1998, Italian journal of gastroenterology and hepatology.

[23]  J. Villeneuve,et al.  Clinical and statistical validity of conventional prognostic factors in predicting short‐term survival among cirrhotics , 1987, Hepatology.

[24]  M. Merli,et al.  Does malnutrition affect survival in cirrhosis? , 1996 .

[25]  E. Christensen,et al.  Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. , 1988, Journal of hepatology.

[26]  R. D. de Man,et al.  Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. , 1992, Gastroenterology.

[27]  P. Angeli,et al.  Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis. , 1998, Journal of hepatology.

[28]  E. Christensen,et al.  Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. , 1994, Journal of hepatology.

[29]  M. Adler,et al.  A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation. , 1992, Transplant international : official journal of the European Society for Organ Transplantation.

[30]  R. Moreau,et al.  Clinical characteristics and outcome of patients with cirrhosis and refractory ascites , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[31]  Y. Nose,et al.  Prediction of the prognosis of liver cirrhosis in Japanese using cox’s proportional hazard model , 1987, Gastroenterologia Japonica.

[32]  R. Bataller,et al.  A prognostic model for predicting survival in cirrhosis with ascites. , 2001, Journal of hepatology.

[33]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.

[34]  G. Aimo,et al.  Monoethylglicinexylidide test: A prognostic indicator of survival in cirrhosis , 1994, Hepatology.

[35]  S. Møller,et al.  Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Copenhagen Esophageal Varices Sclerotherapy Project. , 1994, Journal of hepatology.

[36]  T. Sauerbruch,et al.  Prognostic significance of serum bile acids in cirrhosis , 1986, Hepatology.

[37]  N. Chalasani,et al.  Predictors and Implications of Severe Hypersplenism in Patients with Cirrhosis , 2003, The American journal of the medical sciences.

[38]  T. Gildea,et al.  Cost-Effectiveness of Population Screening for Alpha-1 Antitrypsin Deficiency: A Decision Analysis , 2004, COPD.

[39]  R. Micciolo,et al.  Prognostic score in liver cirrhosis developed using the cox’s proportional hazard regression model , 1987, La Ricerca in Clinica e in Laboratorio.

[40]  J. Villeneuve,et al.  Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end‐to‐side portacaval shunt , 1988, Hepatology.

[41]  James G Kench,et al.  Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.

[42]  G. Marchesini,et al.  The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death , 1996, Hepatology.

[43]  M. Pinzani,et al.  Long course and prognostic factors of virus-induced cirrhosis of the liver. , 1997, The American journal of gastroenterology.

[44]  J. Henriksen,et al.  Prognostic indicators in alcoholic cirrhotic men , 1988, Hepatology.

[45]  R. Franchis,et al.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.

[46]  F. Chan,et al.  Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation , 2002, Journal of clinical gastroenterology.

[47]  N. Mcintyre,et al.  The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage. , 1992, Journal of hepatology.

[48]  G. Marchesini,et al.  Prognostic significance of diabetes in patients with cirrhosis , 1994, Hepatology.

[49]  P. Angeli,et al.  Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. , 1992, Gastroenterology.

[50]  T. Kuroki,et al.  Clinical usefulness of evaluation of portal circulation by per rectal portal scintigraphy with technetium-99m pertechnetate. , 1995, The American journal of gastroenterology.

[51]  C. Cimminiello,et al.  Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group. , 1995, Hepatology.

[52]  M. Romero-Gómez,et al.  Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy , 2004, Hepatology.

[53]  M. Navasa,et al.  Prognostic significance of hepatic encephalopathy in patients with cirrhosis. , 1999, Journal of hepatology.

[54]  T. Poynard,et al.  Prognostic Value of Total Serum Bilirubin/γ‐Glutamyl Transpeptidase Ratio in Cirrhotic Patients , 1984, Hepatology.

[55]  N. Graudal,et al.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. , 1997, Gut.

[56]  W. Jiménez,et al.  Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: Prognostic value of resistive index , 1994, Hepatology.

[57]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[58]  H. Y. Liu,et al.  An analysis of prognostic factors in cirrhosis. , 1989, Chinese medical journal.

[59]  J. Saunders,et al.  A 20-year prospective study of cirrhosis. , 1981, British medical journal.

[60]  G. Teutsch,et al.  A Multivariate Statistical Approach , 2005 .

[61]  P. Angeli,et al.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests , 1999, Hepatology.

[62]  G A Diamond,et al.  Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction. , 1989, Journal of the American College of Cardiology.

[63]  R. Franchis Portal Hypertension IV , 2006 .

[64]  D. Valla,et al.  Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[65]  G. Marchesini,et al.  Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis , 1991, Digestive Diseases and Sciences.

[66]  C. Rodríguez-Ramos,et al.  Adhesion molecules as a prognostic marker of liver cirrhosis , 2005, Scandinavian journal of gastroenterology.

[67]  P. Angeli,et al.  Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. , 1989, Journal of hepatology.

[68]  R. Lamerz,et al.  Predictive value of serum procollagen-III-peptide for the survival of patients with cirrhosis. , 1991, Journal of hepatology.

[69]  B. Gulbis,et al.  Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score. , 1997, Journal of hepatology.

[70]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[71]  P. Vereerstraeten,et al.  Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis , 2005, Digestive Diseases and Sciences.

[72]  L. Martín-Herrera,et al.  Dilutional hyponatremia in patients with cirrhosis and ascites. , 2002, Archives of internal medicine.

[73]  S. Basili,et al.  1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model. , 1992, Scandinavian journal of gastroenterology.

[74]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.

[75]  C. Rodríguez-Ramos,et al.  Implication of inflammation‐related cytokines in the natural history of liver cirrhosis , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[76]  K. Mitamura,et al.  Prognostic Index of Cirrhotic Patients with Hepatic Encephalopathy with and Without Hepatocellular Carcinoma , 2004, Digestive Diseases and Sciences.

[77]  K. Mitamura,et al.  Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma , 2004, Scandinavian journal of gastroenterology.

[78]  A. Maggi,et al.  Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. , 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[79]  M. Christiansen,et al.  Plasma calprotectin: A new prognostic marker of survival in alcohol‐induced cirrhosis , 1995, Hepatology.

[80]  E. Cholongitas,et al.  MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. , 2005, World journal of gastroenterology.

[81]  R. Moreau,et al.  Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis , 2002, American Journal of Gastroenterology.

[82]  S. Ragot,et al.  Cirrhosis and bleeding: the need for very early management. , 2003, Journal of hepatology.

[83]  M. Martínez-Sierra,et al.  Prognostic usefulness of ultrasonographic signs of portal hypertension in patients with Child–Pugh stage A liver cirrhosis , 1999, American Journal of Gastroenterology.

[84]  E Testa,et al.  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study , 2003, Gut.

[85]  P. Thuluvath,et al.  Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[86]  M. Devanlay,et al.  Multivariate analysis of clinical and biological data in cirrhotic patients: application to prognosis , 1981, European journal of clinical investigation.

[87]  E. Christensen,et al.  Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients , 2002, American Journal of Gastroenterology.

[88]  M. Tong,et al.  The long‐term outcomes of patients with compensated hepatitis C virus–related cirrhosis and history of parenteral exposure in the united states , 1999, Hepatology.

[89]  Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. , 1992 .

[90]  J. Jahnsen,et al.  Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit , 2004, Scandinavian journal of gastroenterology.

[91]  D. Valla,et al.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.

[92]  Y. Israel,et al.  Assessment of Prognostic Factors in Alcoholic Liver Disease: Toward a Global Quantitative Expression of Severity , 2007, Hepatology.

[93]  A. Gressner,et al.  Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. , 2003, Journal of hepatology.

[94]  M. Siciliano,et al.  Grading scores and survivorship functions in liver cirrhosis: a comparative statistical analysis of various predictive models. , 1986, Hepato-gastroenterology.

[95]  K. Takase,et al.  Prognostic value of peritoneoscopic findings in cirrhosis of the liver. , 1990, Gastrointestinal endoscopy.

[96]  G. Marchesini,et al.  Prognostic indicators in compensated cirrhosis. , 1991, The American journal of gastroenterology.

[97]  H. Fan,et al.  Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis. , 2002, Hepatobiliary & Pancreatic Diseases International.

[98]  T. Gildea,et al.  Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. , 2004, Chest.

[99]  P. Angeli,et al.  Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. , 2001, Journal of hepatology.

[100]  P. Thuluvath,et al.  Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis. , 2001, Journal of hepatology.

[101]  V. Arroyo,et al.  Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.

[102]  O. Selberg,et al.  Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis , 2002, European Journal of Applied Physiology.

[103]  Y. Nose,et al.  Long‐term prognosis and prognostic factors of liver cirrhosis in the 1980s , 1994, Journal of gastroenterology and hepatology.

[104]  P. Angeli,et al.  Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. , 1989, The American journal of gastroenterology.

[105]  P. Vereerstraeten,et al.  Predictive models of short‐ and long‐term survival in patients with nonbiliary cirrhosis , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[106]  F. Nevens,et al.  Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe , 2001, Journal of viral hepatitis.

[107]  S D Walter,et al.  A comparison of multivariable mathematical methods for predicting survival--III. Accuracy of predictions in generating and challenge sets. , 1990, Journal of clinical epidemiology.

[108]  W. Pandak,et al.  High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[109]  R. Groszmann,et al.  Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. , 1996, Gastroenterology.

[110]  J. Bircher,et al.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. , 1989, Scandinavian journal of gastroenterology.

[111]  J. Sánchez-Payá,et al.  Salivary caffeine clearance predicts survival in patients with liver cirrhosis. , 1997, The American journal of gastroenterology.

[112]  E. Christensen,et al.  Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study , 1994 .

[113]  Jesse A. Berlin,et al.  Assessing the Generalizability of Prognostic Information , 1999 .

[114]  J. Pignon,et al.  Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients , 1985, Hepatology.

[115]  Ramon Planas,et al.  Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. , 2005, The New England journal of medicine.

[116]  S. Chevret,et al.  Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis. , 2005, Gastroenterologie clinique et biologique.

[117]  G. Budillon,et al.  Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. , 1996, Journal of hepatology.

[118]  R. Andrade,et al.  HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis , 2005, Hepatology.

[119]  G. D’Amico,et al.  The incidence of esophageal varices in cirrhosis , 2001 .

[120]  J. Llovet,et al.  Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. , 1993, American Journal of Gastroenterology.

[121]  B. Cesana,et al.  Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. , 1993, The American journal of gastroenterology.

[122]  W. Kremers,et al.  Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[123]  P. Hayes,et al.  Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. , 1998, QJM : monthly journal of the Association of Physicians.

[124]  P. Vereerstraeten,et al.  Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[125]  J. Villeneuve,et al.  A framework for evaluating and conducting prognostic studies: an application to cirrhosis of the liver. , 1989, Journal of clinical epidemiology.

[126]  F. Lacaine,et al.  Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation , 1995, Journal of gastroenterology and hepatology.

[127]  Peter Bacchetti,et al.  Serum sodium predicts mortality in patients listed for liver transplantation , 2005, Hepatology.

[128]  J. Concato,et al.  The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.

[129]  N Tygstrup,et al.  Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. , 1986, Scandinavian journal of gastroenterology.

[130]  M. Ziol,et al.  Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study , 2000, Gut.

[131]  O. Chazouilleres,et al.  Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. , 2000, Journal of hepatology.

[132]  C. Sabin,et al.  Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding , 1999, Gut.

[133]  L. Caregaro,et al.  Nutrition and survival in patients with liver cirrhosis. , 2001, Nutrition.

[134]  N Tygstrup,et al.  Prognostic Factors in Cirrhosis Identified by Cox's Regression Model , 2007, Hepatology.

[135]  O. Chazouilleres,et al.  Determinants of outcome of compensated hepatitis C virus‐related cirrhosis , 1998, Hepatology.

[136]  A. Gatta,et al.  Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis. , 1991, Scandinavian journal of gastroenterology.

[137]  Chang Duck Kim,et al.  Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices , 2004, Journal of gastroenterology and hepatology.

[138]  J. Rodés,et al.  Hemodynamic response to pharmacological treatment of portal hypertension and long‐term prognosis of cirrhosis , 2003, Hepatology.

[139]  S. D. Lee,et al.  Prognostic value of plasma endotoxin levels in patients with cirrhosis. , 1997, Scandinavian journal of gastroenterology.

[140]  F. Harrell,et al.  Regression models for prognostic prediction: advantages, problems, and suggested solutions. , 1985, Cancer treatment reports.

[141]  H. Sørensen,et al.  Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis. , 2003, Hepato-gastroenterology.

[142]  A. Laupacis,et al.  Clinical prediction rules. A review and suggested modifications of methodological standards. , 1997, JAMA.

[143]  F. Mitros,et al.  Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[144]  J. Llach,et al.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. , 1988, Gastroenterology.

[145]  A. França,et al.  Long-term Prognosis of Cirrhosis After Spontaneous Bacterial Peritonitis Treated With Ceftriaxone , 2001, Journal of clinical gastroenterology.

[146]  G. Marchesini,et al.  Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. , 1993, Journal of hepatology.